PFS
AURA icon

Prospera Financial Services’s Aura Biosciences AURA Stock Holding History

Prospera Financial Services’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,181
Closed -$122K – 1120
2024
Q2 		$122K Sell
16,181
-4,245
-21% -$31.1K ﹤0.01% 1095
2024
Q1 		$160K Buy
+20,426
New +$169K ﹤0.01% 1057

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prospera Financial Services's AURA Position: Q3 2024 in Review

Prospera Financial Services sold out of Aura Biosciences (AURA) in Q3 2024, closing a stake of 16,181 shares — an estimated $122K sold.

Prospera Financial Services first reported a position in AURA in Q1 2024 and held it in 2 quarters. The position peaked at $160K in Q1 2024. 81 funds tracked by Wall St. Rank hold AURA as of Q3 2024.

  • Prospera Financial Services reported no remaining Aura Biosciences position as of Q3 2024 after selling out during the quarter.
  • Prospera Financial Services sold 16,181 Aura Biosciences shares in Q3 2024, an estimated $122K.
  • Prospera Financial Services first reported a position in Aura Biosciences in Q1 2024 and held it in 2 quarters.
  • Prospera Financial Services's Aura Biosciences position peaked at $160K in Q1 2024.
  • 81 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2024.

Based on Prospera Financial Services's 13F filing for Q3 2024, filed 7 Nov 2024.